Research Article

Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism

Figure 1

(a) Variations in body weight levels. (b) Variations in blood glucose levels. Variations in (c) BUN, (d) Scr, (e) urinary protein (24-hour urine), and (f) protein/Scr levels at the end of the experiment ( vs. the Sham group; ## vs. the DKD group, ). (g) Hematoxylin and Eosin staining to observe kidney injury in rats (black arrow: dilation of kidney tubules; green arrow: mesangial matrix hyperplasia; red arrow: eosinophils; purple arrow: glomerular hypertrophy). (h) Masson staining to observe kidney fibrosis in rats. (i) Periodic Acid-Silver-Methenamine staining to observe collagen deposition in rats. (j) Masson staining. (k) Statistical analysis results. The statistical results were compared with the Sham operation group and other groups.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(j)
(k)